IL-17 signaling in host defense and inflammatory diseases

被引：0
作者：
Youcun Qian
Zizhen Kang
Caini Liu
Xiaoxia Li
机构：
[1] The Key Laboratory of Stem Cell Biology,Department of Immunology
[2] Institute of Health Sciences,undefined
[3] Shanghai Institutes for Biological Sciences,undefined
[4] Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine,undefined
[5] Lerner Research Institute,undefined
[6] Cleveland Clinic,undefined
来源：
Cellular & Molecular Immunology | 2010年 / 7卷
关键词：
inflammation; interleukin-17; signaling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Interleukin (IL)-17, the signature cytokine secreted by T helper (Th) 17 cells, plays important roles in host defense against extracellular bacterial infection and fungal infection and contributes to the pathogenesis of various autoimmune inflammatory diseases. Here we review the recent advances in IL-17-mediated functions with emphasis on the studies of IL-17-mediated signal transduction, providing perspective on potential drug targets for the treatment of autoimmune inflammatory diseases.
引用
收藏
页码：328 / 333
页数：5
相关论文
共 50 条
  • [31] IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases
    Beringer, Audrey
    Miossec, Pierre
    [J]. AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1176 - 1185
  • [32] The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
    Paquissi, Feliciano Chanana
    Abensur, Hugo
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [33] CXCL12+dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
    Cavagnero, Kellen J.
    Li, Fengwu
    Dokoshi, Tatsuya
    Nakatsuji, Teruaki
    O'Neill, Alan M.
    Aguilera, Carlos
    Liu, Edward
    Shia, Michael
    Osuoji, Olive
    Hata, Tissa
    Gallo, Richard L.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (04)
  • [34] Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
    Rafael-Vidal, Carlos
    Perez, Nair
    Altabas, Irene
    Garcia, Samuel
    Pego-Reigosa, Jose M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 14
  • [35] Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway
    Alvarez-Coiradas, Elia
    Munteanu, Cristian R.
    Diaz-Saez, Laura
    Pazos, Alejandro
    Huber, Kilian V. M.
    Isabel Loza, Maria
    Dominguez, Eduardo
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [36] IL-17: A Critical Cytokine for Defense against Oral Candidiasis
    Dias, Lucas dos Santos
    Lionakis, Michail S.
    [J]. JOURNAL OF IMMUNOLOGY, 2024, 213 (08) : 1049 - 1051
  • [37] Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
    Bunte, Kuebra
    Beikler, Thomas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [38] Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
    Qu, Ning
    Xu, Mingli
    Mizoguchi, Izuru
    Furusawa, Jun-ichi
    Kaneko, Kotaro
    Watanabe, Kazunori
    Mizuguchi, Junichiro
    Itoh, Masahiro
    Kawakami, Yutaka
    Yoshimoto, Takayuki
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [39] The IL-23/IL-17 pathway in inflammatory bowel disease
    Geremia, Alessandra
    Jewell, Derek P.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 223 - 237
  • [40] IL-17 Receptor Signaling: Ubiquitin Gets In On the Act
    Levin, Steven D.
    [J]. SCIENCE SIGNALING, 2009, 2 (92)
12345